More Evidence That ARSIs for Prostate Cancer Differ in Cognitive Effects

(MedPage Today) -- SAN FRANCISCO -- Two widely used androgen receptor signaling inhibitors (ARSIs) had a similar overall effect on cognitive function in men with metastatic castration-resistant prostate cancer (mCRPC) but differed significantly...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news